Ozempic, Wegovy maker Novo Nordisk faces hearing over high …
WEBSep 24, 2024 · WASHINGTON — Sen. Bernie Sanders, I-Vt., on Tuesday extracted a meager commitment from Novo Nordisk CEO Lars Fruergaard Jørgensen to meet with pharmacy benefits managers to discuss lowering the ...
Ozempic and Wegovy drugmaker treating US as its 'cash cow
WEBSep 24, 2024 · Lars Fruergaard Jørgensen, the chief executive of drugmaker Novo Nordisk, said the company is driven by a focus on health, not daily stock prices, and is working to expand manufacturing to meet ...
Novo Nordisk CEO grilled for steep cost of Ozempic and other ... - CBS News
WEBSep 24, 2024 · Novo Nordisk CEO Lars Fruergaard Jørgensen testified before the Senate Health, Education, Labor and Pension committee on Tuesday.
Novo Nordisk CEO grilled over high prices of obesity drugs
WEBNovo Nordisk’s CEO Lars Fruergaard Jørgensen faced tough congressional scrutiny over the high prices of its obesity drugs, Ozempic and Wegovy. Despite efforts to shift blame …
Novo Nordisk's CEO took the Washington hot seat over Ozempic …
WEBNovo Nordisk CEO Lars Fruergaard Jørgensen agreed today, during a Senate committee hearing, to sit ... “The bad news is that they are paying a fortune in premiums, deductibles, and c0-payments ...
Novo Nordisk CEO to testify at Senate hearing over high weight …
WEBSep 24, 2024 · Novo Nordisk CEO Lars Fruergaard Jørgensen will testify at a Senate Health, Education, Labor and Pensions Committee hearing at 10 a.m. ET on Tuesday in Washington, D.C. It comes roughly five ...
Novo Nordisk CEO agrees to testify on semaglutide pricing
WEBNovo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate hearing later this year to defend the pricing of the group’s semaglutide-based …
FT Person of the Year: Lars Fruergaard Jørgensen of Novo Nordisk
WEBDec 19, 2023 · Everything about Lars Fruergaard Jørgensen is understated. The chief executive of Danish drugs group Novo Nordisk grew up on a pig farm in Jutland and from an early age was expected to muck...
Ozempic maker defends high U.S. price: It's 'helping' reduce the …
WEB“If you look at just the cost of obesity in the U.S., it’s a disease that costs Americans more than $400 billion a year,” Lars Fruergaard Jørgensen said in an interview on “NBC …
News Details - Novo Nordisk
WEBJun 24, 2024 · Novo Nordisk plans to invest 4.1 billion US dollars to expand its manufacturing capacity in Clayton, North Carolina, and create 1,000 new jobs. The announcement was made by Lars Fruergaard Jørgensen, president and CEO of Novo Nordisk, on 24 June 2024.